Justin Bowers
Stock Analyst at Deutsche Bank
(2.34)
# 2,451
Out of 4,784 analysts
49
Total ratings
35.48%
Success rate
3.39%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $362.16 | -10.26% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $177.39 | +49.39% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $8.03 | +186.43% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.44 | +35.26% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $92.70 | +8.95% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $312.36 | +7.57% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $9.16 | +172.93% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $133.41 | +16.18% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $500.16 | +21.96% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $58.73 | +39.62% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $16.18 | +54.51% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.36 | +620.34% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $179.07 | +67.53% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $205.85 | +33.59% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $222.20 | +12.51% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $155.55 | +86.44% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.80 | +173.81% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $362.16
Upside: -10.26%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $177.39
Upside: +49.39%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $8.03
Upside: +186.43%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.44
Upside: +35.26%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $92.70
Upside: +8.95%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $312.36
Upside: +7.57%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $9.16
Upside: +172.93%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $133.41
Upside: +16.18%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $500.16
Upside: +21.96%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $58.73
Upside: +39.62%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $16.18
Upside: +54.51%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.36
Upside: +620.34%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $179.07
Upside: +67.53%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $205.85
Upside: +33.59%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $222.20
Upside: +12.51%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $155.55
Upside: +86.44%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.80
Upside: +173.81%